Business Context and Reporting Period
This Form 8-K Current Report was filed by Global Partners LP on October 28, 2022. The filing reports a corporate governance event involving the departure of a senior officer. The company is incorporated in Delaware and its securities trade on the New York Stock Exchange under the symbols GLP, GLP pr A, and GLP pr B.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The document focuses exclusively on executive compensation and separation terms.
Material Changes
The primary material change reported is the resignation of Jeremy (Jez) Langhorn as Chief Human Resources Officer of Global GP LLC (the General Partner), effective October 28, 2022. Mr. Langhorn is departing to pursue other opportunities.
Management Commentary, Risks, and Unusual Items
In connection with the resignation, a Separation Agreement and General Release of Claims was executed. The agreement includes the following compensation and benefits:
- Severance Payment: 200% of base salary plus 200% of the short-term incentive plan target amount.
- Health Benefits: Reimbursement of COBRA premiums for up to 18 months for Mr. Langhorn, his spouse, and eligible dependents.
- Salary Continuation: Continued payment of base salary from the separation date through December 31, 2022.
- Equity Acceleration: Accelerated vesting and full payment of the June 2022 Long-Term Cash Incentive Plan award.
- Phantom Units: Accelerated vesting and cash settlement of all time-based and target performance-based phantom units granted in June 2022.
The filing notes that the description of the Separation Agreement is qualified by reference to the full agreement filed as Exhibit 10.1.
Investor Verification Checklist
- Review Exhibit 10.1 (Separation Agreement) for the complete terms and conditions of the severance package.
- Verify the exact dollar amounts of the base salary and incentive targets to calculate the total severance cost.
- Confirm the appointment of an interim or permanent replacement for the Chief Human Resources Officer role.
- Assess the impact of the accelerated equity vesting on the company's compensation expense for the current fiscal year.